UnitedHealth Group Incorporated $UNH Stock Position Lessened by UMB Bank n.a.

UMB Bank n.a. trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 25.2% during the third quarter, Holdings Channel reports. The institutional investor owned 33,054 shares of the healthcare conglomerate’s stock after selling 11,125 shares during the period. UMB Bank n.a.’s holdings in UnitedHealth Group were worth $11,414,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Victrix Investment Advisors raised its stake in shares of UnitedHealth Group by 91.6% in the 3rd quarter. Victrix Investment Advisors now owns 14,464 shares of the healthcare conglomerate’s stock worth $4,995,000 after buying an additional 6,916 shares in the last quarter. Topsail Wealth Management LLC boosted its position in shares of UnitedHealth Group by 7.5% during the 3rd quarter. Topsail Wealth Management LLC now owns 2,453 shares of the healthcare conglomerate’s stock valued at $847,000 after purchasing an additional 172 shares in the last quarter. Donaldson Capital Management LLC lifted its stake in UnitedHealth Group by 5.2% during the third quarter. Donaldson Capital Management LLC now owns 153,730 shares of the healthcare conglomerate’s stock valued at $53,083,000 after purchasing an additional 7,570 shares during the last quarter. Lee Financial Co acquired a new position in UnitedHealth Group in the third quarter worth approximately $1,170,000. Finally, Independent Advisor Alliance lifted its position in shares of UnitedHealth Group by 28.2% during the 3rd quarter. Independent Advisor Alliance now owns 31,977 shares of the healthcare conglomerate’s stock valued at $11,042,000 after acquiring an additional 7,026 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UNH stock opened at $287.03 on Friday. The company has a market capitalization of $260.00 billion, a price-to-earnings ratio of 21.76, a P/E/G ratio of 1.35 and a beta of 0.42. The firm has a 50 day moving average of $330.74 and a two-hundred day moving average of $323.51. The company has a quick ratio of 0.82, a current ratio of 0.79 and a debt-to-equity ratio of 0.72. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $606.36.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The firm had revenue of $113.22 billion during the quarter, compared to analysts’ expectations of $113.38 billion. During the same period in the prior year, the company posted $6.81 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 3.1%. UnitedHealth Group’s dividend payout ratio is presently 67.02%.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q4 beat and near-term optimism: UNH reported an EPS beat that briefly lifted sentiment and helped the stock rally after the print. That positive earnings surprise shows operations can still deliver despite headwinds. UnitedHealth Group (NYSE:UNH) Shares Up 4% After Earnings Beat
• Positive Sentiment: Potential policy upside: Commentary that UNH is negotiating with the administration for more favorable Medicare rates is a tailwind if realized, supporting longer-term policy risk mitigation. 5 Stocks Primed for a Turnaround in 2026
• Neutral Sentiment: Modest analyst adjustments but continued support: Morgan Stanley trimmed its target slightly while keeping an Overweight rating, signaling analyst conviction remains even as near-term assumptions are revised. UnitedHealth (UNH) Sees Modest Target Cut at Morgan Stanley
• Neutral Sentiment: Investor debate on durability: Several analyst pieces argue the current weakness may be temporary (AI-driven efficiencies, margin recovery) — this creates mixed near-term flows as value buyers size positions vs. risk-averse sellers. UnitedHealth: Opportunity Is Here – Temporary FY2026 Pain
• Negative Sentiment: Analyst price-target cuts: Barclays and Wells Fargo lowered targets (while keeping Overweight ratings), signaling reduced near-term expectations and likely weighing on buying momentum. Analyst Price Target Changes (Benzinga)
• Negative Sentiment: Regulatory/reimbursement pressure: Proposed smaller Medicare reimbursements and government scrutiny of insurer margins remain the largest catalyst for the sell-off and uncertainty around 2026-27 margins. UnitedHealth Plunges After Weak Earnings
• Negative Sentiment: Elevated bearish positioning: Unusual options activity showed a large jump in put buying, indicating short-term hedging or speculative bearish bets that can amplify downward moves. (Options volume data reported 376,697 puts traded vs. average ~163k.)

Analysts Set New Price Targets

Several research firms have issued reports on UNH. Sanford C. Bernstein restated an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday. TD Cowen upped their price target on shares of UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research report on Thursday, October 30th. Leerink Partners cut their target price on shares of UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating on the stock in a research note on Wednesday. Morgan Stanley decreased their target price on UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating for the company in a research report on Friday, January 23rd. Finally, Jefferies Financial Group decreased their price objective on UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating for the company in a research report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $376.75.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.